Tests for Pulmonary Involvement
|Diagnosis of Pulmonary Fibrosis
Diagnosis of Pulmonary Hypertension
Treatment and prognosis of interstitial lung disease in systemic sclerosis (scleroderma). The clinical presentation and diagnosis of scleroderma lung disease and treatments are reviewed here. Uptodate. (Also see What is Scleroderma?)
Biomarkers from bronchoalveolar lavage fluid (BALF) in systemic sclerosis (SSc) patients with interstitial lung disease (ILD) relate to severity of lung fibrosis. In SSc related ILD, biomarkers from BALF and serum correlate to findings on HRCT suggesting usefulness as markers of presence and extent of lung fibrosis. PubMed, Respir Med. (Also see Pulmonary Fibrosis Research and Induced Sputum and Bronchoalveolar Lavage Tests)
Lung tissues in systemic sclerosis (SSc) have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension Unique molecular signatures were generated that are disease- (SSc) and phenotype- (PF vs PAH) specific. Eileen Hsu (PubMed) Arthritis and Rheumatism. (Also see Genetics)
Nail Abnormalities. Disorders that affect the amount of oxygen in the blood (such as abnormal heart anatomy and lung diseases including cancer or infection) may cause clubbing. MedLine Plus.
Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Exercise-induced increase in PASP occurs in almost one-half of patients with systemic sclerosis (SSc) with normal resting pulmonary artery systolic pressure (PASP). Am Heart J.
Lung Density and Pulmonary Artery Diameter (PAD) are Predictors of Pulmonary Hypertension (PH) in Systemic Sclerosis (SSc). In subjects with SSc, lung density and PAD are CT markers, each with predictive value for PH. PubMed, J Thorac Imaging, 2017 Nov;32(6):391-397.
Multimodality Thoracic Imaging of Juvenile Systemic Sclerosis: Emphasis on Clinical Correlation and High-Resolution CT of Pulmonary Fibrosis. Common thoracic findings in juvenile systemic sclerosis and treatment decisions and prognostic assessment are directly related to imaging findings along with clinical evaluation. PubMed, AJR Am J Roentgenol. (Also see Juvenile Scleroderma)
Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis (SSc). The avascular score was associated with higher risk of death and may be a useful tool in prognostic evaluation of SSc. PubMed, Clin Rheumatol, 10/10/2017.
Rationale underlying the measurement of fractional exhaled nitric oxide (FeNO) in systemic sclerosis (SSc) patients. The findings concerning the usefulness of FeNO measurements in SSc patients are discordant, but the available papers suggest that airway/alveolar NO concentration (ANOC) is a more accurate indicator of progressive lung dysfunction. PubMed, Clin Exp Rheumatol, 02/27/2019.
Pulmonary function tests. Pulmonary function tests are a group of tests that measure how well the lungs take in and release air and how well they move gases such as oxygen from the atmosphere into the body's circulation. MedLine Plus.
The early symptoms of pulmonary arterial hypertension (PAH), such as dyspnoea, dizziness, and fatigue, are often mild and are common to many other conditions. At rest there are often no symptoms and no apparent signs of illness.
Usefulness of Six-Minute Walk Test (6MWT) in Systemic Sclerosis. Recent studies suggest two alternatives to the 6MWT: maximal cardiopulmonary exercise testing and DLCO testing during effort. PubMed, Clin Exp Rheumatol, Jul-Aug 2018;36 Suppl 113(4):161-167. (Also see Pulmonary Hypertension Diagnosis)
Six-Minute Walk Test in Scleroderma-Associated Pulmonary Arterial Hypertension: Are We Counting What Counts? The above limitations need to be resolved through further study before the routine use of 6MWT can be recommended for the management of SSc-PAH. The Journal of Rheumatology vol. 36 no. 2 216-218.
High Resolution Computed Tomography
Induced Sputum and Bronchoalveolar Lavage
|Pulmonary Function Tests
Walking and Stress Tests
Pulmonary Fibrosis Antibodies
DLCO in PH
|Markers for PH in Scleroderma
Right Heart Catheterization
We have the world's best supporters! See ISN News.
SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to: